{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:43:24Z","timestamp":1785833004220,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Soonchunhyang University Research Fund and BK21 FOUR","award":["5199990914048"],"award-info":[{"award-number":["5199990914048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s40261-022-01192-0","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T10:05:03Z","timestamp":1661335503000},"page":"853-863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Healthcare Utilization of Patients with Opioid Use Disorder in US Hospitals from 2016 to 2019: Focusing on Racial and Regional Variances"],"prefix":"10.1007","volume":"42","author":[{"given":"Sun Jung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongwha","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"issue":"1","key":"1192_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/S41380-020-0661-4","volume":"26","author":"ND Volkow","year":"2021","unstructured":"Volkow ND, Blanco C. The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry. 2021;26(1):218. https:\/\/doi.org\/10.1038\/S41380-020-0661-4.","journal-title":"Mol Psychiatry"},{"key":"1192_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/J.DRUGPO.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138. https:\/\/doi.org\/10.1016\/J.DRUGPO.2019.01.010.","journal-title":"Int J Drug Policy"},{"key":"1192_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/J.ECLINM.2021.100938","volume":"37","author":"F Qeadan","year":"2021","unstructured":"Qeadan F, Tingey B, Bern R, et al. Opioid use disorder and health service utilization among COVID-19 patients in the US: a nationwide cohort from the Cerner Real-World Data. eClinicalMedicine. 2021;37: 100938. https:\/\/doi.org\/10.1016\/J.ECLINM.2021.100938.","journal-title":"eClinicalMedicine."},{"key":"1192_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/SAR.S135884","volume":"8","author":"DD Maeng","year":"2017","unstructured":"Maeng DD, Han JJ, Fitzpatrick MH, Boscarino JA. Patterns of health care utilization and cost before and after opioid overdose: findings from 10-year longitudinal health plan claims data. Subst Abuse Rehabil. 2017;8:57. https:\/\/doi.org\/10.2147\/SAR.S135884.","journal-title":"Subst Abuse Rehabil."},{"issue":"10182","key":"1192_CR5","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","volume":"393","author":"C Blanco","year":"2019","unstructured":"Blanco C, Volkow ND. Management of opioid use disorder in the USA: present status and future directions. Lancet. 2019;393(10182):1760\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(18)33078-2.","journal-title":"Lancet"},{"issue":"2","key":"1192_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/J.JVAL.2020.07.013","volume":"24","author":"E Beaulieu","year":"2021","unstructured":"Beaulieu E, DiGennaro C, Stringfellow E, et al. Economic evaluation in opioids modeling: systematic review. Value Health. 2021;24(2):158. https:\/\/doi.org\/10.1016\/J.JVAL.2020.07.013.","journal-title":"Value Health."},{"key":"1192_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2020.108382","volume":"217","author":"SM Murphy","year":"2020","unstructured":"Murphy SM. The cost of opioid use disorder and the value of aversion. Drug Alcohol Depend. 2020;217: 108382. https:\/\/doi.org\/10.1016\/J.DRUGALCDEP.2020.108382.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1192_CR8","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/S2468-2667(22)00013-5","volume":"7","author":"C Ju","year":"2022","unstructured":"Ju C, Wei L, Man KKC, et al. Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study. Lancet Public Health. 2022;7(4):e335\u201346. https:\/\/doi.org\/10.1016\/S2468-2667(22)00013-5.","journal-title":"Lancet Public Health."},{"key":"1192_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2020.108127","volume":"214","author":"J van Draanen","year":"2020","unstructured":"van Draanen J, Tsang C, Mitra S, Karamouzian M, Richardson L. Socioeconomic marginalization and opioid-related overdose: a systematic review. Drug Alcohol Depend. 2020;214: 108127. https:\/\/doi.org\/10.1016\/J.DRUGALCDEP.2020.108127.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1192_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12916-018-1058-Y\/TABLES\/4","volume":"16","author":"HY Chang","year":"2018","unstructured":"Chang HY, Kharrazi H, Bodycombe D, Weiner JP, Alexander GC. Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study. BMC Med. 2018;16(1):1\u201311. https:\/\/doi.org\/10.1186\/S12916-018-1058-Y\/TABLES\/4.","journal-title":"BMC Med"},{"issue":"31","key":"1192_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/MMWR.MM6731A1","volume":"67","author":"SC Haight","year":"2018","unstructured":"Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. opioid use disorder documented at delivery hospitalization\u2014United States, 1999\u20132014. Morb Mortal Wkly Rep. 2018;67(31):845. https:\/\/doi.org\/10.15585\/MMWR.MM6731A1.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"5","key":"1192_CR12","doi-asserted-by":"publisher","first-page":"e205852","DOI":"10.1001\/JAMANETWORKOPEN.2020.5852","volume":"3","author":"AS Kilaru","year":"2020","unstructured":"Kilaru AS, Kilaru AS, Xiong A, et al. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3(5):e205852\u2013e205852. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2020.5852.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1192_CR13","doi-asserted-by":"publisher","first-page":"e2032669","DOI":"10.1001\/JAMANETWORKOPEN.2020.32669","volume":"4","author":"H Allen","year":"2021","unstructured":"Allen H, Gordon SH, Lee D, Bhanja A, Sommers BD. Comparison of utilization, costs, and quality of medicaid vs subsidized private health insurance for low-income adults. JAMA Netw Open. 2021;4(1):e2032669\u2013e2032669. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2020.32669.","journal-title":"JAMA Netw Open"},{"key":"1192_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2020.108314","volume":"216","author":"CL Shover","year":"2020","unstructured":"Shover CL, Falasinnu TO, Dwyer CL, et al. Steep increases in fentanyl-related mortality west of the Mississippi River: recent evidence from county and state surveillance. Drug Alcohol Depend. 2020;216: 108314. https:\/\/doi.org\/10.1016\/J.DRUGALCDEP.2020.108314.","journal-title":"Drug Alcohol Depend"},{"issue":"11\u201312","key":"1192_CR15","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/MILMED\/USZ104","volume":"184","author":"BC Lund","year":"2019","unstructured":"Lund BC, Ohl ME, Hadlandsmyth K, Mosher HJ. Regional and rural-urban variation in opioid prescribing in the veterans health administration. Mil Med. 2019;184(11\u201312):894\u2013900. https:\/\/doi.org\/10.1093\/MILMED\/USZ104.","journal-title":"Mil Med"},{"key":"1192_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/J.DRUGPO.2017.06.003","volume":"46","author":"GJ Unick","year":"2017","unstructured":"Unick GJ, Ciccarone D. US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations. Int J Drug Policy. 2017;46:112\u20139. https:\/\/doi.org\/10.1016\/J.DRUGPO.2017.06.003.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1192_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00325481.2018.1407618","volume":"130","author":"J Pergolizzi","year":"2017","unstructured":"Pergolizzi J, LeQuang JA, Taylor R, Raffa RB. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin. Postgrad Med. 2017;130(1):1\u20138. https:\/\/doi.org\/10.1080\/00325481.2018.1407618.","journal-title":"Postgrad Med"},{"key":"1192_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2021.109081","author":"M Kiang","year":"2021","unstructured":"Kiang M, Barnett ML, Wakeman SE, Humphreys K, Tsai AC. Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States. Drug Alcohol Depend. 2021. https:\/\/doi.org\/10.1016\/J.DRUGALCDEP.2021.109081.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1192_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/S11916-022-01010-4\/TABLES\/1","volume":"26","author":"N Siddiqui","year":"2022","unstructured":"Siddiqui N, Urman RD. Opioid use disorder and racial\/ethnic health disparities: prevention and management. Curr Pain Headache Rep. 2022;26(2):129\u201337. https:\/\/doi.org\/10.1007\/S11916-022-01010-4\/TABLES\/1.","journal-title":"Curr Pain Headache Rep"},{"key":"1192_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/J.JSAT.2021.108648","volume":"132","author":"R Rosales","year":"2022","unstructured":"Rosales R, Janssen T, Yermash J, et al. Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19. J Subst Abuse Treat. 2022;132: 108648. https:\/\/doi.org\/10.1016\/J.JSAT.2021.108648.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"1192_CR21","doi-asserted-by":"publisher","first-page":"e203711","DOI":"10.1001\/JAMANETWORKOPEN.2020.3711","volume":"3","author":"WC Goedel","year":"2020","unstructured":"Goedel WC, Shapiro A, Cerd\u00e1 M, Tsai JW, Hadland SE, Marshall BDL. Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States. JAMA Netw Open. 2020;3(4):e203711\u2013e203711. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2020.3711.","journal-title":"JAMA Netw Open"},{"key":"1192_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/J.JSAT.2019.04.001","volume":"101","author":"T Molfenter","year":"2019","unstructured":"Molfenter T, McCarty D, Jacobson N, Kim JS, Starr S, Zehner M. The payer\u2019s role in addressing the opioid epidemic: it\u2019s more than money. J Subst Abuse Treat. 2019;101:72\u20138. https:\/\/doi.org\/10.1016\/J.JSAT.2019.04.001.","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"1192_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0159224","volume":"11","author":"A Singhal","year":"2016","unstructured":"Singhal A, Tien YY, Hsia RY. Racial-ethnic disparities in opioid prescriptions at emergency department visits for conditions commonly associated with prescription drug abuse. PLoS ONE. 2016;11(8): e0159224. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0159224.","journal-title":"PLoS ONE"},{"issue":"1","key":"1192_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/1475-6773.12686","volume":"53","author":"AJ Abraham","year":"2018","unstructured":"Abraham AJ, Andrews CM, Yingling ME, Shannon J. Geographic disparities in availability of opioid use disorder treatment for medicaid enrollees. Health Serv Res. 2018;53(1):389. https:\/\/doi.org\/10.1111\/1475-6773.12686.","journal-title":"Health Serv Res"},{"issue":"1","key":"1192_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.PMN.2020.07.001","volume":"22","author":"S Aronowitz","year":"2021","unstructured":"Aronowitz S, Compton P, Schmidt HD. Innovative approaches to educating future clinicians about opioids, pain, addiction and health policy. Pain Manag Nurs. 2021;22(1):11\u20134. https:\/\/doi.org\/10.1016\/J.PMN.2020.07.001.","journal-title":"Pain Manag Nurs."},{"issue":"10324","key":"1192_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(21)02252-2","volume":"399","author":"K Humphreys","year":"2022","unstructured":"Humphreys K, Shover CL, Andrews CM, et al. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. Lancet. 2022;399(10324):555\u2013604. https:\/\/doi.org\/10.1016\/S0140-6736(21)02252-2.","journal-title":"Lancet"},{"issue":"43","key":"1192_CR27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.15585\/MMWR.MM6843A3","volume":"68","author":"KM Lippold","year":"2019","unstructured":"Lippold KM, Jones CM, Olsen EO, Giroir BP. Racial\/ethnic and age group differences in opioid and synthetic opioid-involved overdose deaths among adults aged \u2265 18 years in metropolitan areas\u2014United States, 2015\u20132017. MMWR Morb Mortal Wkly Rep. 2019;68(43):967\u201373. https:\/\/doi.org\/10.15585\/MMWR.MM6843A3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"1192_CR28","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2105\/AJPH.2021.306431","volume":"111","author":"MR Larochelle","year":"2021","unstructured":"Larochelle MR, Slavova S, Root ED, et al. Disparities in opioid overdose death trends by race\/ethnicity, 2018\u20132019, from the HEALing Communities Study. Am J Public Health. 2021;111(10):1851\u20134. https:\/\/doi.org\/10.2105\/AJPH.2021.306431.","journal-title":"Am J Public Health"},{"key":"1192_CR29","unstructured":"US Census Bureau. Median Household Income and Percent Change by Selected Characteristics. Census.gov. https:\/\/www.census.gov\/content\/dam\/Census\/library\/visualizations\/2020\/demo\/p60-270\/figure1.pdf. Accessed 29 May 2022."},{"key":"1192_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/J.JSAT.2020.108214","volume":"122","author":"MJ Nguemeni Tiako","year":"2021","unstructured":"Nguemeni Tiako MJ. Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19. J Subst Abuse Treat. 2021;122: 108214. https:\/\/doi.org\/10.1016\/J.JSAT.2020.108214.","journal-title":"J Subst Abuse Treat"},{"key":"1192_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/J.JSAT.2019.11.008","volume":"110","author":"KA Hallgren","year":"2020","unstructured":"Hallgren KA, Witwer E, West I, et al. Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network. J Subst Abuse Treat. 2020;110:18\u201327. https:\/\/doi.org\/10.1016\/J.JSAT.2019.11.008.","journal-title":"J Subst Abuse Treat"},{"key":"1192_CR32","unstructured":"US Census Bureau. Rural America. Census.gov. Published 2010. https:\/\/mtgis-portal.geo.census.gov\/arcgis\/apps\/MapSeries\/index.html?appid=49cd4bc9c8eb444ab51218c1d5001ef6. Accessed 31 May 2022."},{"key":"1192_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/J.JSAT.2021.108424","volume":"132","author":"KT Solomon","year":"2022","unstructured":"Solomon KT, Bandara S, Reynolds IS, et al. Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: a state-level trends analysis. J Subst Abuse Treat. 2022;132: 108424. https:\/\/doi.org\/10.1016\/J.JSAT.2021.108424.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"1192_CR34","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/JAMANETWORKOPEN.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622\u2013e1920622. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2019.20622.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1192_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/00325481.2021.1884471","volume":"133","author":"FF Velez","year":"2021","unstructured":"Velez FF, Luderer HF, Gerwien R, Parcher B, Mezzio D, Malone DC. Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder. Postgrad Med. 2021;133(4):421\u20137. https:\/\/doi.org\/10.1080\/00325481.2021.1884471.","journal-title":"Postgrad Med"},{"key":"1192_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/J.JSAT.2018.06.001","volume":"91","author":"AR Williams","year":"2018","unstructured":"Williams AR, Nunes E, Bisaga A, et al. Developing an opioid use disorder treatment cascade: a review of quality measures. J Subst Abuse Treat. 2018;91:57\u201368. https:\/\/doi.org\/10.1016\/J.JSAT.2018.06.001.","journal-title":"J Subst Abuse Treat."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-022-01192-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:07:59Z","timestamp":1744715279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-022-01192-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1192"],"URL":"https:\/\/doi.org\/10.1007\/s40261-022-01192-0","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"7 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This paper was supported by Soonchunhyang University Research Fund and BK21 FOUR (Fostering Outstanding Universities for Research, No.:5199990914048, Korean Ministry of Education). The funding sources did not include study design and data interpretation interventions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Sun Jung Kim, Mar Medina, and Jongwha Chang declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We used secondary data, and all the patient information is encrypted and unable to be identified. This study was approved for a waiver from the Institutional Review Board, Soonchunhyang University (202203-SB-027).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data are available from the corresponding author on request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"JWC and SJK led the design and conception of the study, performed the data analysis, and reviewed the manuscript. MM contributed to the discussion, wrote and edited the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' contributions"}}]}}